Phase
Condition
Dyskinesias
Tardive Dyskinesia
Treatment
N/AClinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- History of using a dopamine receptor antagonist for at least 3 months
- Clinical diagnosis of tardive dyskinesia and has had symptoms for at least 3 monthsprior to screening
- Subjects with underlying psychiatric diagnosis are stable and have no change inpsychoactive medications
- Have a mental health provider and does not anticipate any changes to treatment regimenin the next 3 months
- History of being compliant with prescribed medications
- Able to swallow study drug whole
- Be in good general health and is expected to attend all study visits and completestudy assessments
- Female subjects must not be pregnant and agree to an acceptable method ofcontraception
Exclusion
Exclusion Criteria:
- Currently receiving medication for the treatment of tardive dyskinesia
- Have a neurological condition other than tardive dyskinesia that may interfere withassessing the severity of dyskinesias
- Have a serious untreated or undertreated psychiatric illness
- Have recent history or presence of violent behavior
- Have unstable or serious medical illness
- Have evidence of hepatic impairment
- Have evidence of renal impairment
- Have known allergy to any component of SD-809 or tetrabenazine
- Has participated in an investigational drug or device trial and received study drugwithin 30 days
- Have acknowledged use of illicit drugs
- Have a history of alcohol or substance abuse in the previous 12 months
Study Design
Connect with a study center
Prague,
CzechiaSite Not Available
empty
Bydogoszcz,
PolandSite Not Available
Gdansk,
PolandSite Not Available
Katowice,
PolandSite Not Available
Krakow,
PolandSite Not Available
Lodz,
PolandSite Not Available
Lublin,
PolandSite Not Available
Torun,
PolandSite Not Available
Hronovce,
SlovakiaSite Not Available
empty
Rimavska,
SlovakiaSite Not Available
Roznava,
SlovakiaSite Not Available
Tuscaloosa, Alabama
United StatesSite Not Available
Anaheim, California
United StatesSite Not Available
Glendale, California
United StatesSite Not Available
Oceanside, California
United StatesSite Not Available
Orange, California
United StatesSite Not Available
San Bernardino, California
United StatesSite Not Available
San Diego, California
United StatesSite Not Available
Denver, Colorado
United StatesSite Not Available
New Haven, Connecticut
United StatesSite Not Available
Stamford, Connecticut
United StatesSite Not Available
Washington, District of Columbia
United StatesSite Not Available
empty
Washington, D.C., District of Columbia
United StatesSite Not Available
Boca Raton, Florida
United StatesSite Not Available
Gainesville, Florida
United StatesSite Not Available
Lake City, Florida
United StatesSite Not Available
Miami, Florida
United StatesSite Not Available
Orlando, Florida
United StatesSite Not Available
Port Charlotte, Florida
United StatesSite Not Available
Chicago, Illinois
United StatesSite Not Available
Baltimore, Maryland
United StatesSite Not Available
Minneapolis, Minnesota
United StatesSite Not Available
Kansas City, Missouri
United StatesSite Not Available
Saint Louis, Missouri
United StatesSite Not Available
empty
St. Louis, Missouri
United StatesSite Not Available
Albuquerque, New Mexico
United StatesSite Not Available
Asheville, North Carolina
United StatesSite Not Available
Durham, North Carolina
United StatesSite Not Available
Raleigh, North Carolina
United StatesSite Not Available
Cleveland, Ohio
United StatesSite Not Available
Philadelphia, Pennsylvania
United StatesSite Not Available
Charleston, South Carolina
United StatesSite Not Available
Memphis, Tennessee
United StatesSite Not Available
Fort Worth, Texas
United StatesSite Not Available
Salt Lake City, Utah
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.